Identification of Epigenetic Modifiers Essential for Growth and Survival of AML1/ETO-Positive Leukemia

被引:0
|
作者
Afonso, Jesus Duque [1 ]
Pia, Veratti [2 ]
Rehman, Usama-Ur [3 ]
Herzog, Heike [3 ]
Mitschke, Jan [3 ]
Greve, Gabriele [4 ]
Eble, Julian [3 ]
Berberich, Bettina [3 ]
Thomas, Johanna [5 ]
Pantic, Milena [4 ]
Waterhouse, Miguel [6 ]
Gentile, Gaia [3 ]
Heidenreich, Olaf [7 ]
Miething, Cornelius [6 ,8 ]
Luebbert, Michael [5 ]
机构
[1] Univ Freiburg, Med Ctr, Dept Internal Med 1, Freiburg, Germany
[2] Univ Freiburg, Med Ctr, Dept Internal Med 1, Fac Med, Freiburg, Germany
[3] Univ Freiburg, Univ Freiburg Med Hosp, Dept Hematol Oncol Stem Cell Transplantat, Freiburg, Germany
[4] Univ Freiburg, Med Ctr, Dept Hematol Oncol Stem Cell Transplantat, Freiburg, Germany
[5] Univ Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany
[6] Univ Freiburg, Med Ctr, Freiburg, Germany
[7] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[8] Univ Freiburg, Fac Med, Dept Internal Med 1, Freiburg, Germany
关键词
D O I
10.1182/blood-2023-187372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
    Kai Rejeski
    Jesús Duque-Afonso
    Michael Lübbert
    Oncogene, 2021, 40 : 5665 - 5676
  • [22] Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein
    Fazi, Francesco
    Racanicchi, Serena
    Zardo, Giuseppe
    Stames, Linda M.
    Mancini, Marco
    Travaglini, Lorena
    Diverio, Daniela
    Ammatuna, Emanuele
    Cimino, Giuseppe
    Lo-Coco, Francesco
    Grignani, Francesco
    Nervi, Clara
    CANCER CELL, 2007, 12 (05) : 457 - 466
  • [23] AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
    Rejeski, Kai
    Duque-Afonso, Jesus
    Luebbert, Michael
    ONCOGENE, 2021, 40 (38) : 5665 - 5676
  • [24] DETECTION OF AML1/ETO FUSION TRANSCRIPT AS A TOOL OF DIAGNOSING T(821) POSITIVE ACUTE MYELOGENOUS LEUKEMIA
    MARUYAMA, F
    STASS, SA
    ESTEY, EH
    CORK, A
    HIRANO, M
    INO, T
    FREIREICH, EJ
    YANG, PR
    CHANG, KS
    LEUKEMIA, 1994, 8 (01) : 40 - 45
  • [25] THE AML1 AND ETO GENES IN ACUTE MYELOID-LEUKEMIA WITH A T(821)
    NUCIFORA, G
    ROWLEY, JD
    LEUKEMIA & LYMPHOMA, 1994, 14 (5-6) : 353 - 362
  • [26] Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins
    Barseguian, K
    Lutterbach, B
    Hiebert, SW
    Nickerson, J
    Lian, JB
    Stein, JL
    van Wijnen, AJ
    Stein, GS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) : 15434 - 15439
  • [27] Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells
    Barbetti, V.
    Gozzini, A.
    Rovida, E.
    Morandi, A.
    Spinelli, E.
    Fossati, G.
    Mascagni, P.
    Luebbert, M.
    Dello Sbarba, P.
    Santini, V.
    ONCOGENE, 2008, 27 (12) : 1767 - 1778
  • [28] Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells
    V Barbetti
    A Gozzini
    E Rovida
    A Morandi
    E Spinelli
    G Fossati
    P Mascagni
    M Lübbert
    P Dello Sbarba
    V Santini
    Oncogene, 2008, 27 : 1767 - 1778
  • [29] Bortezomib-induced down-regulation of KIT is mediated by inhibition of Sp1 and NF-kB in AML1/ETO-positive cells.
    Liu, Shujun
    Pang, Jiuxia
    Yu, Jianhua
    Liu, Zhongfa
    Huynh, Lenguyen
    Kearney, Jessica
    Paschka, Peter
    Klisovic, Rebecca B.
    Baiocchi, Robert
    Blum, William
    Perrotti, Danilo
    Marcucci, Guido
    BLOOD, 2006, 108 (11) : 132B - 132B
  • [30] MOLECULAR DIVERSITY IN AML1/ETO FUSION TRANSCRIPTS IN PATIENTS WITH T(821) POSITIVE ACUTE MYELOID-LEUKEMIA
    VANDELOCHT, LTF
    SMETSERS, TFCM
    WITTEBOL, S
    RAYMAKERS, RAP
    MENSINK, EJBM
    LEUKEMIA, 1994, 8 (10) : 1780 - 1784